Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and ValidationZhaoning Zhu, John C. Hunter, Corey Strickland et al.|Journal of Medicinal Chemistry|2009Cited by 121
Application of Fragment-Based NMR Screening, X-ray Crystallography, Structure-Based Design, and Focused Chemical Library Design to Identify Novel μM Leads for the Development of nM BACE-1 (β-Site APP Cleaving Enzyme 1) InhibitorsYu‐Sen Wang, Daniel F. Wyss, Corey Strickland et al.|Journal of Medicinal Chemistry|2009Cited by 102